GMP Problems Put 6 Foreign Firms On Import Alerts Since January
This article was originally published in The Rose Sheet
Executive Summary
FDA's "detention without physical examination" import alerts allows it to " detain affected [import] products if inspection has revealed that a firm is not operating in conformity with" GMPs, though it typically seeks to prevent distribution of a domestic firm's products only after it fails to respond to a warning letter.
You may also be interested in...
Foreign Firms’ Supplement GMP Problems Rival US Warnings
One firm was on FDA’s import alert due to supplement GMP problems at the end of 2014, but more firms in 2015 “have been demonstrated to be non-compliant … to the point that we want to prevent the products from entering the US market,” according to the agency
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.